sns-032

SNS-032 (BMS-387032) is a selective inhibitor of CDK2 (IC50: 48 nM), exhibiting 10- and 20-fold selectivity over CDK1 and CDK4, respectively. It is also sensitive to CDK7 (IC50: 62 nM) and CDK9 (IC50: 4 nM), with no effect on CDK6.

THAL-SNS-032 is a PROTAC designed to selectively degrade CDK9.

Maleimide-Val-Ala-PAB-SNS032 is a conjugated compound used as an ADC toxin and linker. SNS032 acts as a CDK inhibitor, reducing cancer cell viability and arresting the cell cycle at the G1/S phase. Maleimide-Val-Ala-PAB functions as a cleavable ADC linker. Maleimide-Val-Ala-PAB-SNS032 is utilized in the synthesis of ADC molecules.

1,3-Propanediol-SNS-032 is a conjugate of a target protein ligand and linker, utilized in the synthesis of PROTACCDK9 autophagic degrader 1.

DK-TCIP2 is an anticancer agent formed by linking the CDK9 inhibitor SNS-032 and the BCL6 inhibitor BI-3812. This compound exhibits anticancer activity both in vivo and in vitro, making it suitable for research in lymphoma.

CDK-TCIP1 is a bivalent molecule that links the CDK9 inhibitor SNS-032 with the BCL6 ligand BI3812. It effectively and specifically kills cells overexpressing BCL6, with an EC50 of 7.7 nM for SUDHL5 cells.

LC3B recruiter 2 (34R) is an LC3B recruiting agent incorporated into the autophagy-lysosome pathway degradation system (ATTEC, Autophagy-Tethering Compounds), with a direct binding affinity for LC3B. It connects via a linker to the CDK9 inhibitor SNS-032, creating an ATTEC capable of targeting and degrading the CDK9 and Cyclin T1 complex, while also inhibiting them. Consequently, LC3B recruiter 2 exerts its function through an LC3B-dependent autophagy-lysosome pathway, interfering with the cancer cell cycle progression, thereby demonstrating antitumor activity.

Thalidomide-PEG3-NH2 hydrochloride is a Thalidomide-based cereblon ligand that recruits CRBN proteins. This compound can be connected to a target protein ligand via a linker to form a PROTAC molecule, such as THAL-SNS-032.

Thalidomide-4-O-C9-NH2 hydrochloride is a Thalidomide-based cereblon ligand capable of recruiting CRBN protein. This compound can be linked to a target protein ligand via a linker to form PROTAC molecules, such as [THAL-SNS-032].

Thalidomide-4-O-C13-NH2 hydrochloride is a Thalidomide-based cereblon ligand capable of recruiting CRBN proteins. This compound can be joined to a target protein ligand through a linker, leading to the formation of PROTAC molecules, such as [THAL-SNS-032].

Thalidomide-NH-C13-NH2 hydrochloride is a cereblon ligand based on Thalidomide that can recruit CRBN proteins. This compound can be linked to a target protein ligand via a linker to form a PROTAC molecule, such as [THAL-SNS-032].

Thalidomide-5-NH-PEG5-NH2 hydrochloride is a Thalidomide-based cereblon ligand capable of recruiting CRBN proteins. It can connect with a target protein ligand through a linker to form a PROTAC molecule, such as THAL-SNS-032.

Thalidomide-5-NH-PEG6-NH2 hydrochloride is a thalidomide-derived cereblon ligand that recruits CRBN protein. This compound can link with a target protein ligand via a linker to form a PROTAC molecule, such as THAL-SNS-032.

Thalidomide-NH-PEG6-NH2 hydrochloride is a cereblon ligand based on Thalidomide that recruits CRBN proteins. This compound can connect with a target protein ligand via a linker to form a PROTAC molecule, such as THAL-SNS-032.

Thalidomide-4-O-C7-NH2 hydrochloride, a Thalidomide-based cereblon ligand, plays a role in the recruitment of CRBN protein and, when linked to a protein ligand, forms PROTACs [1].

Thalidomide-4-O-C10-NH2 hydrochloride, a Thalidomide-based cereblon ligand, facilitates the recruitment of the CRBN protein. This compound can be conjugated with a protein ligand via a linker to synthesize PROTACs [1].

Thalidomide-5-O-C2-NH2 hydrochloride, a Thalidomide-based cereblon ligand, facilitates the recruitment of CRBN protein and can be conjugated via a linker to form PROTACs [1].

Thalidomide-5-O-C3-NH2 hydrochloride, a Thalidomide-based cereblon ligand, facilitates CRBN protein recruitment and can be conjugated to a protein ligand via a linker to synthesize PROTACs [1].

Thalidomide-5-O-C4-NH2 hydrochloride, a cereblon ligand derived from Thalidomide, facilitates the recruitment of CRBN protein. It can be tethered to a ligand for protein recruitment through a linker, enabling the formation of PROTACs [1].

Thalidomide-5-O-C5-NH2 hydrochloride, a Thalidomide-derived cereblon ligand, facilitates the recruitment of CRBN protein and can be conjugated via a linker to form PROTACs [1].

Thalidomide-5-O-C6-NH2 hydrochloride, a Thalidomide-based cereblon ligand, facilitates the recruitment of CRBN protein and can be conjugated via a linker to another ligand to form proteolysis-targeting chimeras (PROTACs) [1].

Thalidomide-5-O-C7-NH2 hydrochloride, a Thalidomide-based cereblon ligand, facilitates CRBN protein recruitment. This compound can be tethered to a protein-targeting ligand using a linker, enabling the formation of PROTACs [1].

Thalidomide-5-O-C8-NH2 hydrochloride is a Thalidomide-based cereblon ligand that recruits CRBN protein and, when connected to a ligand via a linker, forms PROTACs [1].

Thalidomide-5-O-C9-NH2 hydrochloride, a thalidomide-based cereblon ligand, facilitates the recruitment of the CRBN protein. This compound can be tethered to a protein ligand via a linker, enabling the formation of PROTACs [1].